Zhong Yuan Bio-Technology Holdings Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ZHYBF research report →
Price Chart
About the company
Zhong Yuan Bio-Technology Holdings Limited engages in the sale of plant-derived nervonic acid dietary supplements in China. It operates through four segments: Sales of Dietary Supplements; Research and Development Services; Royalties; and Event Organization. It also develops early detection kits for brain diseases and new drugs for neurological diseases; and technical supporting services.
- CEO
- Ting Ting Chang
- IPO
- 2021
- Employees
- 23
- HQ
- Hong Kong, HK
Get TickerSpark's AI analysis on ZHYBF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $35.75M
- P/E
- 118.82
- PEG
- 0.28
- P/S
- 15.69
- P/B
- -175.27
- EV/EBITDA
- 80.45
- Div Yield
- 0.00%
- Gross Margin
- 90.94%
- Op Margin
- 11.70%
- Net Margin
- 13.27%
- ROE
- -109.67%
- ROIC
- 10.11%
Latest fiscal year · YoY change
- Revenue
- $2.28M+37.0%
- Gross Profit
- $2.07M+36.5%
- Op Income
- $266.56K
- Net Income
- $302.21K+113.5%
- EPS
- $0.02+114.2%
- OCF Growth
- +25.4%
- FCF Growth
- +27.0%
- 52W High
- $2.02
- 52W Low
- $2.02
- 50D MA
- $2.02
- 200D MA
- $2.02
- Beta
- 4.00
- RSI (14)
- 52
- Avg Volume
- 101
No earnings-call transcripts are available for ZHYBF yet.
- Free Float
- 15.8%
- Shares Outstanding
- 17.70M
- Float Shares
- 2.80M
Our ZHYBF coverage
Recent articles, reports, and earnings notes.
No research on ZHYBF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ZHYBF report →